URL | https://www.contractpharma.com/breaking-news/the-n |
Source | Contract Pharma |
Date Published | 03/10/2025 |
Author Name | Charlie Sternberg |
Company/Division name | Halo Industries |
Parent company | Noramco |
Type of work | Manufacturing |
Reshoring category: | Reshoring |
Year reshoring announced: | 2025 |
Capital investment ($): | 25 |
City reshored to: | Whippany |
State(s) reshored to: | NJ |
If relevant, work nearshored to: | - |
Industry(ies): | Chemicals |
Product(s) reshored | pharma and injectibles |
What domestic positive factors made reshoring more attractive? | Automation/technology, Eco-system synergies, Impact on domestic economy, Proximity to customers/market, Raw Materials Cost |